NCT00521131View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

PHASE4CompletedINTERVENTIONAL
Enrollment

453

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
RhinitisAllergicPerennial
Interventions
DRUG

Levocetirizine dihydrochloride

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY